Local Institution - 108

Atlanta, Georgia 30322

0 studies enrolling now · 4 studies all time

What they study most

Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Multiple Myeloma

Studies at this site

• A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas — Completed
• Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leukemia — Stopped early
• A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) — Running, not enrolling
• A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM) — Completed